{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:12:29Z","timestamp":1788437549771,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Application Medical Project of Hefei Municipal Health Commission","award":["Hwk2025yb013"],"award-info":[{"award-number":["Hwk2025yb013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-026-10346-6","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:15:30Z","timestamp":1786328130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of the reduced bone mineral density subgroup among adults with type 2 diabetes mellitus: a retrospective cross-sectional study"],"prefix":"10.1186","volume":"27","author":[{"given":"Song","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-sheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-jia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-shan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-ma","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"10346_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119. Erratum in: Diabetes Res Clin Pract. 2023;204:110945. doi:10.1016\/j.diabres.2023.110945.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10397","key":"10346_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"Lancet"},{"issue":"3","key":"10346_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","volume":"10","author":"LC Hofbauer","year":"2022","unstructured":"Hofbauer LC, Busse B, Eastell R, et al. Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol. 2022;10(3):207\u201320. https:\/\/doi.org\/10.1016\/S2213-8587(21)00347-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10346_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11914-024-00867-1","volume":"22","author":"IAG Brandt","year":"2024","unstructured":"Brandt IAG, Starup-Linde J, Andersen SS, Viggers R. Diagnosing osteoporosis in diabetes: a systematic review on BMD and fractures. Curr Osteoporos Rep. 2024;22(2):223\u201344. https:\/\/doi.org\/10.1007\/s11914-024-00867-1.","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10346_CR5","doi-asserted-by":"publisher","first-page":"ziae003","DOI":"10.1093\/jbmrpl\/ziae003","volume":"8","author":"SR Emerzian","year":"2024","unstructured":"Emerzian SR, Johannesdottir F, Yu EW, Bouxsein ML. Use of noninvasive imaging to identify causes of skeletal fragility in adults with diabetes: a review. JBMR Plus. 2024;8(2):ziae003. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae003.","journal-title":"JBMR Plus"},{"issue":"3","key":"10346_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s12020-024-03926-w","volume":"85","author":"GF Li","year":"2024","unstructured":"Li GF, Zhao PP, Xiao WJ, Karasik D, Xu YJ, Zheng HF. The paradox of bone mineral density and fracture risk in type 2 diabetes. Endocrine. 2024;85(3):1100\u20133. https:\/\/doi.org\/10.1007\/s12020-024-03926-w.","journal-title":"Endocrine"},{"key":"10346_CR7","doi-asserted-by":"publisher","first-page":"116569","DOI":"10.1016\/j.bone.2022.116569","volume":"165","author":"IAG Brandt","year":"2022","unstructured":"Brandt IAG, Jessen MH, Rimestad DE, Hojgaard MKF, Vestergaard P. Advanced glycation end products and bone: how do we measure them and how do they correlate with bone mineral density and fractures? A systematic review and evaluation of precision of measures. Bone. 2022;165:116569. https:\/\/doi.org\/10.1016\/j.bone.2022.116569.","journal-title":"Bone"},{"key":"10346_CR8","doi-asserted-by":"publisher","first-page":"116880","DOI":"10.1016\/j.bone.2023.116880","volume":"176","author":"B Wang","year":"2023","unstructured":"Wang B, Vashishth D. Advanced glycation and glycoxidation end products in bone. Bone. 2023;176:116880. https:\/\/doi.org\/10.1016\/j.bone.2023.116880.","journal-title":"Bone"},{"issue":"4","key":"10346_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/MED.0000000000000736","volume":"29","author":"GE Sroga","year":"2022","unstructured":"Sroga GE, Stephen SJ, Wang B, Vashishth D. Techniques for advanced glycation end product measurements for diabetic bone disease: pitfalls and future directions. Curr Opin Endocrinol Diabetes Obes. 2022;29(4):333\u201342. https:\/\/doi.org\/10.1097\/MED.0000000000000736.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"10346_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12891-022-05314-9","volume":"23","author":"LC Gassel","year":"2022","unstructured":"Gassel LC, Schneider S, Banke IJ, et al. Dysregulation of Wnt signaling in bone of type 2 diabetes mellitus and diabetic Charcot arthropathy. BMC Musculoskelet Disord. 2022;23(1):365. https:\/\/doi.org\/10.1186\/s12891-022-05314-9.","journal-title":"BMC Musculoskelet Disord"},{"key":"10346_CR11","doi-asserted-by":"publisher","first-page":"1330171","DOI":"10.3389\/fphys.2024.1330171","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Zhang Y, Liu X, Chen B, Lei L. Effect of type 2 diabetes on biochemical markers of bone metabolism: a meta-analysis. Front Physiol. 2024;15:1330171. https:\/\/doi.org\/10.3389\/fphys.2024.1330171.","journal-title":"Front Physiol"},{"issue":"7","key":"10346_CR12","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1210\/clinem\/dgad043","volume":"108","author":"MI Nasser","year":"2023","unstructured":"Nasser MI, Stidsen JV, Hojlund K, Nielsen JS, Eastell R, Frost M. Low bone turnover associates with lower insulin sensitivity in newly diagnosed drug-naive persons with type 2 diabetes. J Clin Endocrinol Metab. 2023;108(7):e371\u20139. https:\/\/doi.org\/10.1210\/clinem\/dgad043.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10346_CR13","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1210\/clinem\/dgad255","volume":"108","author":"C Meier","year":"2023","unstructured":"Meier C, Eastell R, Pierroz DD, et al. Biochemical markers of bone fragility in patients with diabetes. J Clin Endocrinol Metab. 2023;108(10):e923\u201336. https:\/\/doi.org\/10.1210\/clinem\/dgad255.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10346_CR14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1210\/clinem\/dgab061","volume":"106","author":"F Vigevano","year":"2021","unstructured":"Vigevano F, Gregori G, Colleluori G, et al. In men with obesity, type 2 diabetes is associated with poor trabecular microarchitecture and bone strength and low bone turnover. J Clin Endocrinol Metab. 2021;106(5):1362\u201376. https:\/\/doi.org\/10.1210\/clinem\/dgab061.","journal-title":"J Clin Endocrinol Metab"},{"key":"10346_CR15","doi-asserted-by":"publisher","first-page":"990667","DOI":"10.3389\/fendo.2022.990667","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Huang R, Tang PT, Tu M, Guo XL. Perirenal fat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022;13:990667. https:\/\/doi.org\/10.3389\/fendo.2022.990667.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10346_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12902-024-01698-y","volume":"24","author":"S Wei","year":"2024","unstructured":"Wei S, Pan X, Wei J. Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord. 2024;24(1):179. https:\/\/doi.org\/10.1186\/s12902-024-01698-y.","journal-title":"BMC Endocr Disord"},{"key":"10346_CR17","doi-asserted-by":"publisher","first-page":"1035853","DOI":"10.3389\/fnut.2022.1035853","volume":"9","author":"T Gao","year":"2022","unstructured":"Gao T, Liu F, Ban B, et al. Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus. Front Nutr. 2022;9:1035853. https:\/\/doi.org\/10.3389\/fnut.2022.1035853.","journal-title":"Front Nutr"},{"key":"10346_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/DMSO.S388919","volume":"16","author":"J Yang","year":"2023","unstructured":"Yang J, Zheng C, Wang Y, Yang L, Liu L. Correlation between mean amplitude of glycemic excursion and bone turnover markers in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:397\u2013407. https:\/\/doi.org\/10.2147\/DMSO.S388919.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10346_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12020-022-03090-z","volume":"77","author":"Z Li","year":"2022","unstructured":"Li Z, Qi C, Pan X, et al. The relationship between estimated glucose disposal rate and bone turnover markers in type 2 diabetes mellitus. Endocrine. 2022;77(2):242\u201351. https:\/\/doi.org\/10.1007\/s12020-022-03090-z.","journal-title":"Endocrine"},{"issue":"4","key":"10346_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","volume":"36","author":"HP Bhattoa","year":"2025","unstructured":"Bhattoa HP, Vasikaran S, Trifonidi I, et al. Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporos Int. 2025;36(4):579\u2013608. https:\/\/doi.org\/10.1007\/s00198-025-07422-3.","journal-title":"Osteoporos Int"},{"key":"10346_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jot.2024.06.003","volume":"47","author":"W Lin","year":"2024","unstructured":"Lin W, Chow SKH, Cui C, et al. Wnt\/beta-catenin signaling pathway as an important mediator in muscle and bone crosstalk: a systematic review. J Orthop Translat. 2024;47:63\u201373. https:\/\/doi.org\/10.1016\/j.jot.2024.06.003.","journal-title":"J Orthop Translat"},{"issue":"1","key":"10346_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00223-023-01146-4","volume":"114","author":"C Smith","year":"2024","unstructured":"Smith C, Sim M, Dalla Via J, Levinger I, Duque G. The interconnection between muscle and bone: a common clinical management pathway. Calcif Tissue Int. 2024;114(1):24\u201337. https:\/\/doi.org\/10.1007\/s00223-023-01146-4.","journal-title":"Calcif Tissue Int"},{"key":"10346_CR23","doi-asserted-by":"publisher","first-page":"116789","DOI":"10.1016\/j.bone.2023.116789","volume":"173","author":"G Duque","year":"2023","unstructured":"Duque G, Kirk B, Arai H. Strong muscles lead to strong bones: the connection between osteoporosis, sarcopenia, falls and fractures. Bone. 2023;173:116789. https:\/\/doi.org\/10.1016\/j.bone.2023.116789.","journal-title":"Bone"},{"issue":"1","key":"10346_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11657-023-01247-5","volume":"18","author":"Y Liu","year":"2023","unstructured":"Liu Y, Song Y, Hao Q, Wu J. Global prevalence of osteosarcopenic obesity amongst middle-aged and older adults: a systematic review and meta-analysis. Arch Osteoporos. 2023;18(1):60. https:\/\/doi.org\/10.1007\/s11657-023-01247-5.","journal-title":"Arch Osteoporos"},{"issue":"3","key":"10346_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3803\/EnM.2024.2002","volume":"39","author":"BJ Kim","year":"2024","unstructured":"Kim BJ. Beyond bone: embracing osteosarcopenia for comprehensive fracture prevention. Endocrinol Metab (Seoul). 2024;39(3):531\u20133. https:\/\/doi.org\/10.3803\/EnM.2024.2002.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"10346_CR26","doi-asserted-by":"publisher","first-page":"101437","DOI":"10.1016\/j.jocd.2023.101437","volume":"27","author":"D Krueger","year":"2024","unstructured":"Krueger D, Tanner SB, Szalat A, et al. DXA reporting updates: 2023 Official Positions of the International Society for Clinical Densitometry. J Clin Densitom. 2024;27(1):101437. https:\/\/doi.org\/10.1016\/j.jocd.2023.101437.","journal-title":"J Clin Densitom"},{"issue":"1","key":"10346_CR27","doi-asserted-by":"publisher","first-page":"101440","DOI":"10.1016\/j.jocd.2023.101440","volume":"27","author":"LU Gani","year":"2024","unstructured":"Gani LU, Sritara C, Blank RD, et al. Follow-up bone mineral density testing: 2023 Official Positions of the International Society for Clinical Densitometry. J Clin Densitom. 2024;27(1):101440. https:\/\/doi.org\/10.1016\/j.jocd.2023.101440. Corrigendum in: J Clin Densitom. 2025;28(1):101540. doi:10.1016\/j.jocd.2024.101540.","journal-title":"J Clin Densitom"},{"issue":"2","key":"10346_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00259-024-06912-6","volume":"52","author":"RHJA Slart","year":"2025","unstructured":"Slart RHJA, Punda M, Ali DS, et al. Updated practice guideline for dual-energy X-ray absorptiometry. Eur J Nucl Med Mol Imaging. 2025;52(2):539\u201363. https:\/\/doi.org\/10.1007\/s00259-024-06912-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11S","key":"10346_CR29","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.1016\/j.jacr.2022.09.007","volume":"19","author":"JS Yu","year":"2022","unstructured":"Yu JS, Krishna NG, Fox MG, et al. ACR Appropriateness Criteria Osteoporosis and Bone Mineral Density: 2022 Update. J Am Coll Radiol. 2022;19(11S):S417\u201332. https:\/\/doi.org\/10.1016\/j.jacr.2022.09.007.","journal-title":"J Am Coll Radiol"},{"issue":"11","key":"10346_CR30","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s40618-023-02082-8","volume":"46","author":"G Adami","year":"2023","unstructured":"Adami G, Biffi A, Porcu G, et al. A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS. J Endocrinol Invest. 2023;46(11):2287\u201397. https:\/\/doi.org\/10.1007\/s40618-023-02082-8.","journal-title":"J Endocrinol Invest"},{"key":"10346_CR31","doi-asserted-by":"publisher","first-page":"e081250","DOI":"10.1136\/bmj-2024-081250","volume":"390","author":"CWS Hoong","year":"2025","unstructured":"Hoong CWS, Saul D, Khosla S, Sfeir JG. Advances in the management of osteoporosis. BMJ. 2025;390:e081250. https:\/\/doi.org\/10.1136\/bmj-2024-081250.","journal-title":"BMJ"},{"issue":"11","key":"10346_CR32","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00198-023-06829-0","volume":"34","author":"AK Schumm","year":"2023","unstructured":"Schumm AK, Craige EA, Arora NK, et al. Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis. Osteoporos Int. 2023;34(11):1867\u201380. https:\/\/doi.org\/10.1007\/s00198-023-06829-0.","journal-title":"Osteoporos Int"},{"issue":"11","key":"10346_CR33","doi-asserted-by":"publisher","first-page":"e10817","DOI":"10.1002\/jbm4.10817","volume":"7","author":"R Viggers","year":"2023","unstructured":"Viggers R, Rasmussen NH, Vestergaard P. Effects of incretin therapy on skeletal health in type 2 diabetes: a systematic review. JBMR Plus. 2023;7(11):e10817. https:\/\/doi.org\/10.1002\/jbm4.10817.","journal-title":"JBMR Plus"},{"issue":"6","key":"10346_CR34","doi-asserted-by":"publisher","first-page":"e3843","DOI":"10.1002\/dmrr.3843","volume":"40","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Choi SA, Gu MS, et al. Effects of glucagon-like peptide-1 receptor agonist on bone mineral density and bone turnover markers: a meta-analysis. Diabetes Metab Res Rev. 2024;40(6):e3843. https:\/\/doi.org\/10.1002\/dmrr.3843.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10346_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12902-024-01575-8","volume":"24","author":"J Wang","year":"2024","unstructured":"Wang J, Li X, Li Y, Lei C. Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMC Endocr Disord. 2024;24(1):52. https:\/\/doi.org\/10.1186\/s12902-024-01575-8.","journal-title":"BMC Endocr Disord"},{"key":"10346_CR36","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Dhiman P, Ma J, et al. TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. https:\/\/doi.org\/10.1136\/bmj-2023-078378.","journal-title":"BMJ"},{"key":"10346_CR37","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray TPA, Egger M, Salanti G. Developing clinical prediction models: a step-by-step guide. BMJ. 2024;386:e078276. https:\/\/doi.org\/10.1136\/bmj-2023-078276.","journal-title":"BMJ"},{"issue":"4","key":"10346_CR38","doi-asserted-by":"publisher","first-page":"101602","DOI":"10.1016\/j.jocd.2025.101602","volume":"28","author":"ABM Kamrul-Hasan","year":"2025","unstructured":"Kamrul-Hasan ABM, Bhattacharya S, Ganakumar V, et al. Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis. J Clin Densitom. 2025;28(4):101602. https:\/\/doi.org\/10.1016\/j.jocd.2025.101602.","journal-title":"J Clin Densitom"},{"issue":"6","key":"10346_CR39","doi-asserted-by":"publisher","first-page":"101276","DOI":"10.1016\/j.diabet.2021.101276","volume":"47","author":"M Hayon-Ponce","year":"2021","unstructured":"Hayon-Ponce M, Garcia-Fontana B, Aviles-Perez MD, et al. Lower trabecular bone score in type 2 diabetes mellitus: a role for fat mass and insulin resistance beyond hyperglycaemia. Diabetes Metab. 2021;47(6):101276. https:\/\/doi.org\/10.1016\/j.diabet.2021.101276.","journal-title":"Diabetes Metab"},{"issue":"11","key":"10346_CR40","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1111\/dom.15890","volume":"26","author":"V Van Hulten","year":"2024","unstructured":"Van Hulten V, Driessen JHM, Andersen S, et al. Fracture risk revisited: bone mineral density T-score and fracture risk in type 2 diabetes. Diabetes Obes Metab. 2024;26(11):5325\u201335. https:\/\/doi.org\/10.1111\/dom.15890.","journal-title":"Diabetes Obes Metab"},{"key":"10346_CR41","doi-asserted-by":"publisher","first-page":"832977","DOI":"10.3389\/fendo.2022.832977","volume":"13","author":"V Van Hulten","year":"2022","unstructured":"Van Hulten V, Sarodnik C, Driessen JHM, et al. Prevalent morphometrically assessed vertebral fractures in individuals with type 2 diabetes, prediabetes and normal glucose metabolism: The Maastricht Study. Front Endocrinol (Lausanne). 2022;13:832977. https:\/\/doi.org\/10.3389\/fendo.2022.832977.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10346_CR42","doi-asserted-by":"publisher","first-page":"116220","DOI":"10.1016\/j.bone.2021.116220","volume":"154","author":"JT Schousboe","year":"2022","unstructured":"Schousboe JT, Morin SN, Kline GA, et al. Differential risk of fracture attributable to type 2 diabetes mellitus according to skeletal site. Bone. 2022;154:116220. https:\/\/doi.org\/10.1016\/j.bone.2021.116220.","journal-title":"Bone"},{"issue":"1","key":"10346_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13098-021-00707-7","volume":"13","author":"Y Ai","year":"2021","unstructured":"Ai Y, Xu R, Liu L. The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):93. https:\/\/doi.org\/10.1186\/s13098-021-00707-7.","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"10346_CR44","doi-asserted-by":"publisher","first-page":"102835","DOI":"10.1016\/j.dsx.2023.102835","volume":"17","author":"A Marcotte-Chenard","year":"2023","unstructured":"Marcotte-Chenard A, Oliveira B, Little JP, Candow DG. Sarcopenia and type 2 diabetes: pathophysiology and potential therapeutic lifestyle interventions. Diabetes Metab Syndr. 2023;17(9):102835. https:\/\/doi.org\/10.1016\/j.dsx.2023.102835.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10346_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.20945\/2359-3997000000418","volume":"65","author":"LM Pechmann","year":"2021","unstructured":"Pechmann LM, Petterle RR, Moreira CA, Borba VZC. Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus. Arch Endocrinol Metab. 2021;65(6):801\u201310. https:\/\/doi.org\/10.20945\/2359-3997000000418.","journal-title":"Arch Endocrinol Metab"},{"issue":"11","key":"10346_CR46","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/jbmr.4697","volume":"37","author":"R Eastell","year":"2022","unstructured":"Eastell R, Vittinghoff E, Lui LY, et al. Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk. J Bone Min Res. 2022;37(11):2121\u201331. https:\/\/doi.org\/10.1002\/jbmr.4697.","journal-title":"J Bone Min Res"},{"issue":"7","key":"10346_CR47","doi-asserted-by":"publisher","first-page":"bvae112","DOI":"10.1210\/jendso\/bvae112","volume":"8","author":"P Forner","year":"2024","unstructured":"Forner P, Sheu A. Bone health in patients with type 2 diabetes. J Endocr Soc. 2024;8(7):bvae112. https:\/\/doi.org\/10.1210\/jendso\/bvae112.","journal-title":"J Endocr Soc"},{"key":"10346_CR48","doi-asserted-by":"publisher","first-page":"111904","DOI":"10.1016\/j.diabres.2024.111904","volume":"217","author":"J Wang","year":"2024","unstructured":"Wang J, Wei Z, Wang Y, et al. Pancreatic fat infiltration is associated with risk of vertebral fracture in older patients with type 2 diabetes: a longitudinal multicenter study. Diabetes Res Clin Pract. 2024;217:111904. https:\/\/doi.org\/10.1016\/j.diabres.2024.111904.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10346_CR49","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/jbmr\/zjae068","volume":"39","author":"M Schini","year":"2024","unstructured":"Schini M, Vilaca T, Lui LY, et al. Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project. J Bone Min Res. 2024;39(7):867\u201376. https:\/\/doi.org\/10.1093\/jbmr\/zjae068.","journal-title":"J Bone Min Res"},{"issue":"5","key":"10346_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.tem.2022.02.006","volume":"33","author":"A Sheu","year":"2022","unstructured":"Sheu A, Greenfield JR, White CP, Center JR. Assessment and treatment of osteoporosis and fractures in type 2 diabetes. Trends Endocrinol Metab. 2022;33(5):333\u201344. https:\/\/doi.org\/10.1016\/j.tem.2022.02.006.","journal-title":"Trends Endocrinol Metab"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-10346-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10346-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10346-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:14:10Z","timestamp":1788434050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-026-10346-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10346"],"URL":"https:\/\/doi.org\/10.1186\/s12891-026-10346-6","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Medical Research Ethics Review Committee of The Third People\u2019s Hospital of Hefei (Ethics Approval No. 2026LLWL032). The approval document addressed the scientific, informed-consent, and ethical aspects of the study and granted approval for submission and publication. The retrospective analysis used de-identified routinely collected clinical data and involved no additional examination, intervention, biological sampling, or participant contact. The consent arrangements were reviewed and approved by the committee. All procedures were conducted in accordance with the Declaration of Helsinki and applicable institutional and national ethical requirements.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript contains no identifiable individual-level information, images, or clinical details requiring consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"756"}}